Cldi stock price the latest CLDI stock price closed at

The latest CLDI stock price closed at $2.84, marking a 1.43% uptick in today’s trading session, backed by moderate volume of 1.2M shares. Technical indicators suggest short-term momentum is bullish, but investors are watching resistance near $3.00 for potential breakout patterns. Calidi Biotherapeutics, Inc. (CLDI) : Free Stock Analysis Report Calidi Biotherapeutics (NYSE American: CLDI ) is a clinical-stage immuno-oncology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary Redtail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. This advanced enveloped technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent gene therapies to metastatic locations. CLDI stock price rose to $2.84, outperforming peer group averages in the small-cap digital media sector. Sector resilience is helping prop valuations despite broader market caution.